Revvity PE Ratio 2010-2025 | RVTY
Current and historical p/e ratio for Revvity (RVTY) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Revvity PE ratio as of August 22, 2025 is 19.25.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Revvity PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-22 | 94.15 | 39.89 | |
| 2025-06-30 | 96.65 | $2.36 | 40.95 |
| 2025-03-31 | 105.64 | $2.35 | 44.95 |
| 2024-12-31 | 111.38 | $2.21 | 50.40 |
| 2024-09-30 | 127.41 | $2.07 | 61.55 |
| 2024-06-30 | 104.52 | $1.38 | 75.74 |
| 2024-03-31 | 104.58 | $1.21 | 86.43 |
| 2023-12-31 | 108.80 | $5.50 | 19.78 |
| 2023-09-30 | 110.11 | $5.95 | 18.51 |
| 2023-06-30 | 118.09 | $6.54 | 18.06 |
| 2023-03-31 | 132.41 | $7.68 | 17.24 |
| 2022-12-31 | 139.25 | $4.58 | 30.40 |
| 2022-09-30 | 119.43 | $4.90 | 24.37 |
| 2022-06-30 | 141.09 | $5.34 | 26.42 |
| 2022-03-31 | 173.00 | $6.11 | 28.31 |
| 2021-12-31 | 199.30 | $8.08 | 24.67 |
| 2021-09-30 | 171.70 | $10.05 | 17.08 |
| 2021-06-30 | 152.93 | $10.51 | 14.55 |
| 2021-03-31 | 126.99 | $9.55 | 13.30 |
| 2020-12-31 | 141.98 | $6.48 | 21.91 |
| 2020-09-30 | 124.11 | $3.68 | 33.73 |
| 2020-06-30 | 96.93 | $2.63 | 36.86 |
| 2020-03-31 | 74.33 | $2.02 | 36.79 |
| 2019-12-31 | 95.80 | $2.04 | 46.96 |
| 2019-09-30 | 83.96 | $2.10 | 39.98 |
| 2019-06-30 | 94.90 | $2.27 | 41.81 |
| 2019-03-31 | 94.85 | $2.22 | 42.73 |
| 2018-12-31 | 77.26 | $2.13 | 36.27 |
| 2018-09-30 | 95.59 | $1.12 | 85.35 |
| 2018-06-30 | 71.90 | $1.25 | 57.52 |
| 2018-03-31 | 74.28 | $2.52 | 29.48 |
| 2017-12-31 | 71.66 | $2.64 | 27.15 |
| 2017-09-30 | 67.53 | $3.60 | 18.76 |
| 2017-06-30 | 66.65 | $3.31 | 20.14 |
| 2017-03-31 | 56.72 | $2.05 | 27.67 |
| 2016-12-31 | 50.88 | $2.13 | 23.89 |
| 2016-09-30 | 54.67 | $2.15 | 25.43 |
| 2016-06-30 | 51.01 | $2.10 | 24.29 |
| 2016-03-31 | 48.06 | $1.95 | 24.65 |
| 2015-12-31 | 51.98 | $1.88 | 27.65 |
| 2015-09-30 | 44.53 | $1.54 | 28.92 |
| 2015-06-30 | 50.94 | $1.43 | 35.62 |
| 2015-03-31 | 49.42 | $1.44 | 34.32 |
| 2014-12-31 | 42.19 | $1.38 | 30.57 |
| 2014-09-30 | 41.99 | $1.68 | 24.99 |
| 2014-06-30 | 45.04 | $1.67 | 26.97 |
| 2014-03-31 | 43.26 | $1.48 | 29.23 |
| 2013-12-31 | 39.52 | $1.46 | 27.07 |
| 2013-09-30 | 36.12 | $0.75 | 48.15 |
| 2013-06-30 | 31.03 | $0.65 | 47.73 |
| 2013-03-31 | 32.05 | $0.69 | 46.45 |
| 2012-12-31 | 30.18 | $0.61 | 49.47 |
| 2012-09-30 | 27.96 | $0.00 | 0.00 |
| 2012-06-30 | 24.40 | $0.05 | 488.09 |
| 2012-03-31 | 26.10 | $0.01 | 2609.55 |
| 2011-12-31 | 18.81 | $0.01 | 1881.06 |
| 2011-09-30 | 18.00 | $3.22 | 5.59 |
| 2011-06-30 | 25.15 | $3.02 | 8.33 |
| 2011-03-31 | 24.49 | $3.26 | 7.51 |
| 2010-12-31 | 24.00 | $3.27 | 7.34 |
| 2010-09-30 | 21.44 | $1.15 | 18.65 |
| 2010-06-30 | 19.09 | $1.16 | 16.45 |
| 2010-03-31 | 22.00 | $0.85 | 25.89 |
| 2009-12-31 | 18.89 | $0.73 | 25.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.928B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.660B | 28.13 |
| CVS Health (CVS) | United States | $90.432B | 11.25 |
| Elevance Health (ELV) | United States | $71.280B | 9.59 |
| Cencora (COR) | United States | $56.729B | 18.89 |
| DiDi Global (DIDIY) | China | $27.580B | 29.30 |
| Labcorp Holdings (LH) | United States | $23.117B | 18.37 |
| Natera (NTRA) | United States | $22.728B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.699B | 0.00 |
| ICON (ICLR) | Ireland | $14.200B | 13.66 |
| Medpace Holdings (MEDP) | United States | $13.025B | 34.47 |
| CochLear (CHEOY) | Australia | $12.814B | 0.00 |
| Solventum (SOLV) | United States | $12.753B | 13.16 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $11.052B | 0.00 |
| Avantor (AVTR) | United States | $9.047B | 13.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.007B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.965B | 15.11 |
| HealthEquity (HQY) | United States | $7.767B | 34.02 |
| Bausch + Lomb (BLCO) | Canada | $5.289B | 35.57 |
| Sotera Health (SHC) | United States | $4.667B | 26.08 |
| BrightSpring Health Services (BTSG) | United States | $4.406B | 33.61 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| KindlyMD (NAKA) | United States | $3.810B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.696B | 84.65 |
| Alignment Healthcare (ALHC) | United States | $3.137B | 0.00 |
| Concentras Parent (CON) | United States | $3.031B | 19.23 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| Organon (OGN) | United States | $2.451B | 2.67 |
| Premier (PINC) | United States | $2.070B | 19.19 |
| Progyny (PGNY) | United States | $2.023B | 42.78 |
| Ardent Health (ARDT) | United States | $1.858B | 7.17 |
| PACS (PACS) | United States | $1.836B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.584B | 26.82 |
| Pediatrix Medical (MD) | United States | $1.481B | 9.89 |
| Teladoc Health (TDOC) | United States | $1.357B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.264B | 0.00 | |
| Omada Health (OMDA) | $1.227B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.841B | 4.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 9.83 |
| CareDx (CDNA) | United States | $0.690B | 12.72 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| Agilon Health (AGL) | United States | $0.551B | 0.00 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 6.87 |
| SBC Medicals (SBC) | United States | $0.444B | 9.75 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.442B | 0.00 |
| Enhabit (EHAB) | United States | $0.415B | 27.30 |
| So-Young (SY) | China | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.338B | 0.00 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.280B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.145B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| ModivCare (MODV) | United States | $0.015B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |